The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis?Pierre Dourlen, Jean‐Charles Lambert, Devrim Kilinc et al.|Acta Neuropathologica|2019Cited by 170
Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathologyPierre Dourlen, Bart Dermaut, Mikko Hiltunen et al.|Molecular Psychiatry|2016Cited by 119
Tau phosphorylation regulates the interaction between BIN1’s SH3 domain and Tau’s proline-rich domainYoann Sottejeau, Jean‐Charles Lambert, Alexis Bretteville et al.|Acta Neuropathologica Communications|2015Cited by 98
Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolismJean‐Charles Lambert, Julien Chapuis, Amandine Flaig et al.|Acta Neuropathologica|2016Cited by 78
BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr348 phosphorylationMaxime Sartori, Jean‐Charles Lambert, Tiago Mendes et al.|Acta Neuropathologica|2019Cited by 76